We conducted a randomized controlled trial to determine whether intensive multi-agent adjuvant chemotherapy improves the chances of relapse-free survival in patients with nonmetastatic high-grade osteosarcoma of the extremity, as compared with concurrent controls. After undergoing definitive surgery, 36 patients were randomly assigned to adjuvant chemotherapy or to observation without adjuvant treatment. At two years the actuarial relapse-free survival was 17 percent in the control group, similar to that found in studies before 1970, and 66 percent in the adjuvant-chemotherapy group (P less than 0.001). Similar results were observed among 77 additional patients who declined to undergo randomization but who elected observation or chemotherapy. We conclude that the natural history of osteosarcoma of the extremity has remained stable over the past two decades, that adjuvant chemotherapy increases the chances of relapse-free survival of patients with high-grade osteosarcoma, and that it should be given to all such patients.
This article has been cited by other articles:
RICHARDSEN, E., SORBYE, S. W., CROWE, J. P., YANG, J.-L., BUSUND, L.-T.
(2009). Expression of M-CSF and CSF-1R Is Correlated with Histological Grade in Soft Tissue Tumors. Anticancer Res
29: 3861-3866
[Abstract][Full Text]
Schuetze, S. M., Patel, S.
(2009). Should Patients with High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy?. The Oncologist
14: 1003-1012
[Abstract][Full Text]
Wu, P. K., Chen, W. M., Chen, C. F., Lee, O. K., Haung, C. K., Chen, T. H.
(2009). Primary Osteogenic Sarcoma with Pulmonary Metastasis: Clinical Results and Prognostic Factors in 91 Patients. Jpn J Clin Oncol
39: 514-522
[Abstract][Full Text]
Aljubran, A. H., Griffin, A., Pintilie, M., Blackstein, M.
(2009). Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases. Ann Oncol
20: 1136-1141
[Abstract][Full Text]
de Nigris, F., Rossiello, R., Schiano, C., Arra, C., Williams-Ignarro, S., Barbieri, A., Lanza, A., Balestrieri, A., Giuliano, M. T., Ignarro, L. J., Napoli, C.
(2008). Deletion of Yin Yang 1 Protein in Osteosarcoma Cells on Cell Invasion and CXCR4/Angiogenesis and Metastasis. Cancer Res.
68: 1797-1808
[Abstract][Full Text]
Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., Kleinerman, E., Link, M. P., Nadel, H., Nieder, M., Siegal, G. P., Weiner, M. A., Wells, R. J., Womer, R. B., Grier, H. E.
(2008). Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival--A Report From the Children's Oncology Group. JCO
26: 633-638
[Abstract][Full Text]
Bacci, G., Balladelli, A., Forni, C., Ferrari, S., Longhi, A., Benassi, M. S., Briccoli, A., Serra, M., Picci, P.
(2007). Adjuvant and neo-adjuvant chemotherapy for Ewing's sarcoma family tumors and osteosarcoma of the extremity: further outcome for patients event-free survivors 5 years from the beginning of treatment. Ann Oncol
18: 2037-2040
[Abstract][Full Text]
Skubitz, K. M., D'Adamo, D. R.
(2007). Sarcoma. Mayo Clin Proc.
82: 1409-1432
[Abstract][Full Text]
Gordon, N., Koshkina, N. V., Jia, S.-F., Khanna, C., Mendoza, A., Worth, L. L., Kleinerman, E. S.
(2007). Corruption of the Fas Pathway Delays the Pulmonary Clearance of Murine Osteosarcoma Cells, Enhances Their Metastatic Potential, and Reduces the Effect of Aerosol Gemcitabine. Clin. Cancer Res.
13: 4503-4510
[Abstract][Full Text]
Huang, G., Mills, L., Worth, L. L.
(2007). Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells. Molecular Cancer Therapeutics
6: 1610-1619
[Abstract][Full Text]
Orosco, A., Fromigue, O., Bazille, C., Entz-Werle, N., Levillain, P., Marie, P. J., Modrowski, D.
(2007). Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma. Cancer Res.
67: 3708-3715
[Abstract][Full Text]
Welsh, J. S.
(2007). Radiographically Identified Necrosis After 90Y Microsphere Brachytherapy: A New Standard for Oncologic Response Assessment?. Am. J. Roentgenol.
188: 765-767
[Full Text]
Lewis, I. J., Nooij, M. A., Whelan, J., Sydes, M. R., Grimer, R., Hogendoorn, P. C. W., Memon, M. A., Weeden, S., Uscinska, B. M., van Glabbeke, M., Kirkpatrick, A., Hauben, E. I., Craft, A. W., Taminiau, A. H. M.
(2007). Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup. JNCI J Natl Cancer Inst
99: 112-128
[Abstract][Full Text]
Gupta, A., Meswania, J., Pollock, R., Cannon, S. R., Briggs, T. W. R., Taylor, S., Blunn, G.
(2006). Non-invasive distal femoral expandable endoprosthesis for limb-salvage surgery in paediatric tumours. J Bone Joint Surg Br
88-B: 649-654
[Abstract][Full Text]
Petrilli, A. S., de Camargo, B., Filho, V. O., Bruniera, P., Brunetto, A. L., Jesus-Garcia, R., Camargo, O. P., Pena, W., Pericles, P., Davi, A., Prospero, J. D., Alves, M. T. S., Oliveira, C. R., Macedo, C. R.D., Mendes, W. L., Almeida, M. T. A., Borsato, M. L., dos Santos, T. M., Ortega, J., Consentino, E.
(2006). Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: Prognostic Factors and Impact on Survival. JCO
24: 1161-1168
[Abstract][Full Text]
Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T. A., Picci, P., Capanna, R., Bernini, G., Muller, C., Tienghi, A., Wiebe, T., Comandone, A., Bohling, T., Del Prever, A. B., Brosjo, O., Bacci, G., Saeter, G.
(2005). Neoadjuvant Chemotherapy With High-Dose Ifosfamide, High-Dose Methotrexate, Cisplatin, and Doxorubicin for Patients With Localized Osteosarcoma of the Extremity: A Joint Study by the Italian and Scandinavian Sarcoma Groups. JCO
23: 8845-8852
[Abstract][Full Text]
Shafran, A., Ifergan, I., Bram, E., Jansen, G., Kathmann, I., Peters, G. J., Robey, R. W., Bates, S. E., Assaraf, Y. G.
(2005). ABCG2 Harboring the Gly482 Mutation Confers High-Level Resistance to Various Hydrophilic Antifolates. Cancer Res.
65: 8414-8422
[Abstract][Full Text]
Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., Bernstein, M. L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A. M., Harris, M. B., Healey, J., Huvos, A., Link, M., Montebello, J., Nadel, H., Nieder, M., Sato, J., Siegal, G., Weiner, M., Wells, R., Wold, L., Womer, R., Grier, H.
(2005). Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate. JCO
23: 2004-2011
[Abstract][Full Text]
(2005). Pathology Quiz Case 2--Diagnosis. Arch Otolaryngol Head Neck Surg
131: 175-176
[Full Text]
Perissinotto, E., Cavalloni, G., Leone, F., Fonsato, V., Mitola, S., Grignani, G., Surrenti, N., Sangiolo, D., Bussolino, F., Piacibello, W., Aglietta, M.
(2005). Involvement of Chemokine Receptor 4/Stromal Cell-Derived Factor 1 System during Osteosarcoma Tumor Progression. Clin. Cancer Res.
11: 490-497
[Abstract][Full Text]
Wright, J. G., Gebhardt, M. C.
(2005). Multicenter Clinical Trials in Orthopaedics: Time for Musculoskeletal Specialty Societies to Take Action. JBJS
87: 214-217
[Full Text]
Kreuter, M., Bieker, R., Bielack, S. S., Auras, T., Buerger, H., Gosheger, G., Jurgens, H., Berdel, W. E., Mesters, R. M.
(2004). Prognostic Relevance of Increased Angiogenesis in Osteosarcoma. Clin. Cancer Res.
10: 8531-8537
[Abstract][Full Text]
Lafleur, E. A., Koshkina, N. V., Stewart, J., Jia, S.-F., Worth, L. L., Duan, X., Kleinerman, E. S.
(2004). Increased Fas Expression Reduces the Metastatic Potential of Human Osteosarcoma Cells. Clin. Cancer Res.
10: 8114-8119
[Abstract][Full Text]
Marina, N., Gebhardt, M., Teot, L., Gorlick, R.
(2004). Biology and Therapeutic Advances for Pediatric Osteosarcoma. The Oncologist
9: 422-441
[Abstract][Full Text]
Paluska, S. A.
(2003). Persistent Knee Pain in a Recreational Runner. J Am Board Fam Med
16: 435-442
[Full Text]
Jia, S.-F., Worth, L. L., Densmore, C. L., Xu, B., Duan, X., Kleinerman, E. S.
(2003). Aerosol Gene Therapy with PEI: IL-12 Eradicates Osteosarcoma Lung Metastases. Clin. Cancer Res.
9: 3462-3468
[Abstract][Full Text]
Goorin, A. M., Schwartzentruber, D. J., Devidas, M., Gebhardt, M. C., Ayala, A. G., Harris, M. B., Helman, L. J., Grier, H. E., Link, M. P.
(2003). Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651. JCO
21: 1574-1580
[Abstract][Full Text]
Aung, L., Gorlick, R., Healey, J. H., Shi, W., Thaler, H. T., Shorter, N. A., Huvos, A. G., Meyers, P. A.
(2003). Metachronous Skeletal Osteosarcoma in Patients Treated with Adjuvant and Neoadjuvant Chemotherapy for Nonmetastatic Osteosarcoma. JCO
21: 342-348
[Abstract][Full Text]
Nagarajan, R., Neglia, J. P., Clohisy, D. R., Robison, L. L.
(2002). Limb Salvage and Amputation in Survivors of Pediatric Lower-Extremity Bone Tumors: What Are the Long-Term Implications?. JCO
20: 4493-4501
[Abstract][Full Text]
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., Zoubek, A., Jurgens, H., Winkler, K.
(2002). Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols. JCO
20: 776-790
[Abstract][Full Text]
Goorin, A. M., Harris, M. B., Bernstein, M., Ferguson, W., Devidas, M., Siegal, G. P., Gebhardt, M. C., Schwartz, C. L., Link, M., Grier, H. E.
(2002). Phase II/III Trial of Etoposide and High-Dose Ifosfamide in Newly Diagnosed Metastatic Osteosarcoma: A Pediatric Oncology Group Trial. JCO
20: 426-433
[Abstract][Full Text]
Ahmad, S. A., Patel, S. R., Ballo, M. T., Baker, T. P., Yasko, A. W., Wang, X., Feig, B. W., Hunt, K. K., Lin, P. P., Weber, K. L., Chen, L. L., Zagars, G. K., Pollock, R. E., Benjamin, R. S., Pisters, P. W.T.
(2002). Extraosseous Osteosarcoma: Response to Treatment and Long-Term Outcome. JCO
20: 521-527
[Abstract][Full Text]
Scully, S. P., Ghert, M. A., Zurakowski, D., Thompson, R. C., Gebhardt, M. C.
(2002). Pathologic Fracture in Osteosarcoma : Prognostic Importance and Treatment Implications. JBJS
84: 49-57
[Abstract][Full Text]
Gibbs, C. P. Jr., Weber, K., Scarborough, M. T.
(2001). Malignant Bone Tumors. JBJS
83: 1728-1745
[Full Text]
Lafleur, E. A., Jia, S.-F., Worth, L. L., Zhou, Z., Owen-Schaub, L. B., Kleinerman, E. S.
(2001). Interleukin (IL)-12 and IL-12 Gene Transfer Up-Regulate Fas Expression in Human Osteosarcoma and Breast Cancer Cells. Cancer Res.
61: 4066-4071
[Abstract][Full Text]
Meyer, W. H., Pratt, C. B., Poquette, C. A., Rao, B. N., Parham, D. M., Marina, N. M., Pappo, A. S., Mahmoud, H. H., Jenkins, J. J., Harper, J., Neel, M., Fletcher, B. D.
(2001). Carboplatin/Ifosfamide Window Therapy for Osteosarcoma: Results of the St Jude Children's Research Hospital OS-91 Trial. JCO
19: 171-182
[Abstract][Full Text]
Bacci, G., Ferrari, S., Bertoni, F., Ruggieri, P., Picci, P., Longhi, A., Casadei, R., Fabbri, N., Forni, C., Versari, M., Campanacci, M.
(2000). Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report. JCO
18: 4016-4027
[Abstract][Full Text]
Lewis, I. J., Weeden, S., Machin, D., Stark, D., Craft, A. W.
(2000). Received Dose and Dose-Intensity of Chemotherapy and Outcome in Nonmetastatic Extremity Osteosarcoma. JCO
18: 4028-4037
[Abstract][Full Text]
Worth, L. L., Jia, S.-F., Zhou, Z., Chen, L., Kleinerman, E. S.
(2000). Intranasal Therapy with an Adenoviral Vector Containing the Murine Interleukin-12 Gene Eradicates Osteosarcoma Lung Metastases. Clin. Cancer Res.
6: 3713-3718
[Abstract][Full Text]
Wunder, J. S., Bull, S. B., Aneliunas, V., Lee, P. D., Davis, A. M., Beauchamp, C. P., Conrad, E. U., Grimer, R. J., Healey, J. H., Rock, M. J., Bell, R. S., Andrulis, I. L.
(2000). MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study. JCO
18: 2685-2694
[Abstract][Full Text]
Arndt, C. A.S., Crist, W. M.
(1999). Common Musculoskeletal Tumors of Childhood and Adolescence. NEJM
341: 342-352
[Full Text]
Antunes, M., Bernardo, J., Salete, M., Prieto, D., Eugenio, L., Tavares, P.
(1999). Excision of pulmonary metastases of osteogenic sarcoma of the limbs. Eur. J. Cardiothorac. Surg.
15: 592-596
[Abstract][Full Text]
Pratt, C. B., Pappo, A. S., Gieser, P., Jenkins, J. J., Neff, J., Rao, B., Green, D., Thomas, P., Marcus, R., Parham, D., Maurer, H.
(1999). Role of Adjuvant Chemotherapy in the Treatment of Surgically Resected Pediatric Nonrhabdomyosarcomatous Soft Tissue Sarcomas: A Pediatric Oncology Group Study. JCO
17: 1219-1219
[Abstract][Full Text]
ORTIZ-CRUZ, E., GEBHARDT, M. C., JENNINGS, L. C., SPRINGFIELD, D. S., MANKIN, H. J.
(1997). The Results of Transplantation of Intercalary Allografts after Resection of Tumors. A Long-Term Follow-Up Study. JBJS
79: 97-106
[Abstract][Full Text]
Smith, M., Abrams, J., Trimble, E. L., Ungerleider, R. S.
(1996). Dose Intensity of Chemotherapy for Childhood Cancers. The Oncologist
1: 293-304
[Abstract][Full Text]
Lipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., Colan, S. D.
(1995). Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer. NEJM
332: 1738-1744
[Abstract][Full Text]
Paz, I. B., Wagman, L. D., Terz, J. J., Chandrasekhar, B., Lorant, J. A., Moscarello, G. M., Odom-Maryon, T.
(1992). Extended Indications for Functional Limb-Sparing Surgery in Extremity Sarcoma Using Complex Reconstruction. Arch Surg
127: 1278-1281
[Abstract]
Previous
